keyword
https://read.qxmd.com/read/38130534/drug-induced-linear-iga-bullous-dermatosis-in-an-oncologic-patient
#21
Luz A Quispe-Gárate, Renzo B Espinoza-Escudero, Carlos Salas-Rivera, Gadwyn Sánchez-Félix
Blister formation in the skin can result from various conditions, such as autoimmune disorders, drug reactions, infections, etc. A comprehensive patient assessment may offer clues for diagnosis. Linear IgA bullous dermatosis (LABD) is a rare subepidermal blistering disorder characterized by the deposition of IgA at the basement membrane zone of the skin and mucous membranes. Here, we describe a case of a patient with a new onset of painless blisters located in the skin and oral mucosa after initiating antibiotic treatment...
November 2023: Curēus
https://read.qxmd.com/read/38099111/immunohistochemical-evaluation-of-c4d-and-c3d-markers-in-bullous-pemphigoid-as-a-substitute-for-direct-immunofluorescence-technique
#22
JOURNAL ARTICLE
Mahsa Akbari Oryani, Naser Tayebi-Meybodi, Yalda Nahidi, Mohsen Soltani Sabi, Monavar Afzal Aghaei
BACKGROUND: There are several methods for the diagnosis of autoimmune bullous disease. Direct immunofluorescent (DIF) testing is an important diagnostic method in the diagnosis of immunobullous disease but requires skilled pathologist, fresh tissue and well-equipped laboratory to perform the procedure. The immunohistochemistry analysis of C4d and C3d is easily compared with other methods. This study was conducted to assess the value of immunohistochemistry (IHC) analysis for expressions of C3d and C4d in the diagnosis of bullous pemphigoid (BP)...
2023: Indian Journal of Dermatology
https://read.qxmd.com/read/37954538/bullous-hemorrhagic-dermatosis-induced-by-enoxaparin-about-a-case-in-madagascar
#23
Fenohasina Rakotonandrasana, Fandresena Arilala Sendrasoa, Andrianandrianina Mbolatiana Kiady Armando Rakotomanana, Herin'Ny Fitiavana Princia Andriatahina, Voahanginirina Nathalie Ralimalala, Samson Léophonte Ramily, Moril Sata, Onivola Raharolahy, Malalaniaina Andrianarison, Irina Mamisoa Ranaivo, Lala Soavina Ramarozatovo, Fahafahantsoa Rapelanoro Rabenja
Bullous hemorrhagic dermatosis is an adverse reaction occurring within 5 to 21 days after anticoagulation; the diagnosis is to be evoked in the presence of hemorrhagic bullous lesions at a distance from the injection site in the days following the introduction of anticoagulant; this is a diagnosis of exclusion. It is a rare pathology that mainly affects the elderly. A 54-year-old man presented with bullous hemorrhagic lesions on the left upper limb starting at the 4th day after enoxaparin injection, diagnosed as a bullous hemorrhagic dermatosis induced by enoxaparin...
2023: Case Reports in Dermatological Medicine
https://read.qxmd.com/read/37897588/advancing-treatment-in-bullous-pemphigoid-a-comprehensive-review-of-novel-therapeutic-targets-and-approaches
#24
REVIEW
Hsuan-Chi Chen, Chuang-Wei Wang, Wu Han Toh, Hua-En Lee, Wen-Hung Chung, Chun-Bing Chen
Bullous pemphigoid is one of the most common autoimmune bullous diseases occurring primarily in the elderly. Pathogenic autoantibodies against BP180 and BP230 at the dermal-epidermal junction cause subepidermal blisters, erosions, and intense pruritus, all of which adversely affect the patients' quality of life and may increase their morbidity and mortality. Current systemic treatment options for bullous pemphigoid are limited to corticosteroids and immunosuppressants, which can have substantial side effects on these vulnerable patients that even exceed their therapeutic benefits...
December 2023: Clinical Reviews in Allergy & Immunology
https://read.qxmd.com/read/37881435/retrospective-analysis-of-autoimmune-bullous-diseases-in-middle-franconia
#25
JOURNAL ARTICLE
Lukas Sollfrank, Valerie Schönfelder, Micheal Sticherling
INTRODUCTION: Autoimmune bullous diseases (AIBDs) are a group of rare cutaneous disorders affecting cornified skin and mucous membranes. They are characterized by tense or flaccid blistering and erosions due to autoantibodies against desmosomal and hemidesmosomal structural proteins of the skin. This group of disorders can be divided into those of pemphigoid and those of pemphigus diseases. If left untreated, these autoimmune diseases can cause serious or even life-threatening complications such as loss of fluid, superinfections or impaired food intake...
2023: Frontiers in Immunology
https://read.qxmd.com/read/37877093/revisiting-the-jelly-roll-technique-new-utility-in-diagnosing-linear-iga-bullous-dermatosis-mimicking-toxic-epidermal-necrolysis
#26
Samavia Khan, Edward Bae, Regine J Mathieu, Christopher Elco, Cathy M Massoud, Elnaz F Firoz
No abstract text is available yet for this article.
November 2023: JAAD Case Reports
https://read.qxmd.com/read/37853876/cutaneous-cytomegalovirus-infection-presenting-as-recalcitrant-bullous-pemphigoid-lesion
#27
Gayun Baek, Taehan Koo, Min-Soo Kim, Mihn-Sook Jue
Cytomegalovirus (CMV) infection is common among immunocompromised hosts; however, its cutaneous manifestation is considered rare in comparison to internal organ involvement. Clinical manifestations of cutaneous CMV infection generally include perioral or perianal ulcerations. On the other hand, autoimmune bullous dermatosis can have bullae and ulcerations similar to those caused by cutaneous CMV infection. Autoimmune bullous dermatosis requires treatment with immunosuppressive agents for relatively long periods, which may cause reduction of immunocompetence...
May 2023: Annals of Dermatology
https://read.qxmd.com/read/37843581/-management-of-bullous-pemphigoid-and-mucous-membrane-pemphigoid
#28
REVIEW
Johannes S Kern, Silke C Hofmann
BACKGROUND: Bullous pemphigoid (BP) is the most common blistering autoimmune dermatosis and, as an age-associated disease, is also the bullous dermatosis with the highest increase in incidence in recent years due to demographic developments. Mucous membrane pemphigoid (MMP), which is less common, is a clinically and immunopathologically heterogeneous blistering autoimmune dermatosis characterized by blisters and erosions on mucous membranes. OBJECTIVE: This work summarizes the manifold clinical characteristics of both diseases and provides an up-to-date overview of diagnostics and therapy of BP and SHP...
October 16, 2023: Dermatologie (Heidelb)
https://read.qxmd.com/read/37842150/linear-iga-bullous-dermatosis-induced-by-nemvaleukin-alfa-an-engineered-interleukin-2-molecule-in-a-patient-with-treatment-refractory-metastatic-melanoma
#29
Fatima Bawany, Vignesh Ramachandran, Eduardo Rodriguez, Randie H Kim, Jeffrey S Weber, Ian W Tattersall
No abstract text is available yet for this article.
November 2023: JAAD Case Reports
https://read.qxmd.com/read/37790051/gluten-intolerance-and-its-association-with-skin-disorders-a-narrative-review
#30
REVIEW
Vaibhav Vats, Pallavi Makineni, Sarah Hemaida, Anum Haider, Sachin Subramani, Navjot Kaur, Amna Naveed Butt, Renee Scott-Emuakpor, Mohammad Zahir, Midhun Mathew, Javed Iqbal
Gluten sensitivity is defined as a chronic intolerance to gluten ingestion in genetically predisposed individuals. The etiology is thought to be immune-mediated and has a variable dermatologic presentation. Celiac disease (CD) is one of the most common forms of gluten intolerance and encompasses a wide range of extra-intestinal pathology, including cutaneous, endocrine, nervous, and hematologic systems. Psoriasis, another long-term inflammatory skin condition, has been linked to significant symptomatic improvement with a gluten-free diet (GFD)...
September 2023: Curēus
https://read.qxmd.com/read/37731671/development-of-cyclosporine-induced-linear-iga-bullous-dermatosis-despite-concurrent-use-of-dapsone
#31
Karissa Libson, Kristin L Koenig, Catherine G Chung, Abraham M Korman
No abstract text is available yet for this article.
October 2023: JAAD Case Reports
https://read.qxmd.com/read/37692847/case-report-ribociclib-induced-phototoxicity-presented-as-dyschromia-with-subsequent-bullae-formation
#32
Jyun-Yan Jhan, Wei-En Wang, Sung-Chao Chu, Chiu-Hsuan Cheng, Chung-Hsing Chang
Ribociclib, a cyclin-dependent kinase 4/6 inhibitor, is a novel targeted therapy for advanced-stage breast cancer. Although ribociclib-induced cutaneous side effects have been previously noted, they have not been well documented. Herein, we present a case of ribociclib-induced phototoxicity, which manifested as dyschromia over sun-exposed forearms and neck initially and as bullae formation subsequently. A 71-year-old woman with metastatic breast cancer developed dyschromia after daily treatment with ribociclib (600 mg) for 7 months...
2023: Frontiers in Oncology
https://read.qxmd.com/read/37652095/a-celiac-gene-hla-dqb1-02-01-is-associated-with-linear-iga-bullous-dermatosis-in-chinese-population
#33
JOURNAL ARTICLE
Lichen Li, Lele Sun, Gongqi Yu, Qianqian Xia, Tingting Liu, Qing Zhao, Zhenzhen Wang, Chuan Wang, Baoqi Yang, Yongxia Liu, Xuechao Chen, Shengli Chen, Guizhi Zhou, Hong Liu, Yonghu Sun, Furen Zhang
No abstract text is available yet for this article.
August 29, 2023: Journal of Investigative Dermatology
https://read.qxmd.com/read/37605396/stevens-johnson-syndrome-and-toxic-epidermal-necrolysis-an-overview-of-diagnosis-therapy-options-and-prognosis-of-patients
#34
JOURNAL ARTICLE
Vivek Kumar Garg, Harpal S Buttar, Sajad Ahmad Bhat, Nuftieva Ainur, Tannu Priya, Dharambir Kashyap, Hardeep Singh Tuli
Both Stevens-Johnson syndrome (SJS) and Toxic-epidermal necrolysis (TEN) are generally medication-induced pathological conditions that mostly affect the epidermis and mucus membranes. Nearly 1 to 2 patients per 1,000,000 population are affected annually with SJS and TEN, and sometimes these maladies can cause serious life-threatening events. The reported death rates for SJS range from 1 to 5%, and 25 to 35% for TEN. The mortality risk may even be higher among elderly patients, especially in those who are affected by a significant amount of epidermal detachment...
August 21, 2023: Recent advances in inflammation & allergy drug discovery
https://read.qxmd.com/read/37600741/successful-treatment-of-linear-immunoglobulin-a-bullous-dermatosis-with-dupilumab-in-a-pediatric-patient
#35
Nouf Almuhanna, Rasha Alhamazani, Sarah Alkhezzi, Mahdi T Alfataih, Salman Al-Malki, Anwar R Alrashidi, Faris A Alhomida
No abstract text is available yet for this article.
August 2023: JAAD Case Reports
https://read.qxmd.com/read/37586570/ocular-involvement-in-autoimmune-bullous-diseases
#36
JOURNAL ARTICLE
Marta Kurzeja, Malgorzata Olszewska, Andrzej Grzybowski, Lidia Rudnicka
Autoimmune bullous diseases represent a heterogenous group of disorders caused by autoantibodies against adhesion molecules; the location of the target protein determines the level of cleft formation. The spectrum of ocular lesions in autoimmune bullous diseases can range from mild symptoms to severe involvement with sight impairment and even, in some cases, blindness. In pemphigus vulgaris, the prevalence of ocular involvement has been reported to be between 7% and 26%. The most common clinical sign of ocular pemphigus vulgaris is bilateral conjunctivitis with hyperemia...
August 14, 2023: Clinics in Dermatology
https://read.qxmd.com/read/37550175/detection-of-a-natural-antibody-targeting-the-shed-ectodomain-of-bp180-in-mice
#37
JOURNAL ARTICLE
Yosuke Mai, Kentaro Izumi, Shoko Mai, Wataru Nishie, Hideyuki Ujiie
BACKGROUND: Pemphigoid diseases are characterized by subepidermal blister formation accompanied by autoantibodies targeting skin component molecules, such as BP180. It is suggested that an epitope-phenotype correlation exists among autoantibodies recognizing BP180. However, it is unclear which regions of BP180 are likely targets for autoantibodies. OBJECTIVE: To elucidate the portions of BP180 where antibodies tend to react under the breakdown of immune tolerance...
August 1, 2023: Journal of Dermatological Science
https://read.qxmd.com/read/37485225/linear-iga-bullous-dermatosis-attributable-to-the-use-of-spironolactone-a-case-report
#38
Vineetha Philip, Olushola O Ogunleye, Nneka Chukwu, Isaac Rosenblum, Susan Collins
Linear IgA bullous dermatosis (LABD) is a rare, idiopathic, or drug-induced vesiculobullous disease caused by IgA autoantibodies in the basement membrane zone. An 84-year-old man was started on spironolactone two weeks before presentation for the management of hypertension and heart failure with preserved ejection fraction. He presented to our hospital for evaluation of worsening lower extremity swelling and a painful pruritic rash that started on the day preceding his presentation. On examination, he had 3+ lower extremity edema and an erythematous, painful, pruritic, bullous rash on all his extremities...
June 2023: Curēus
https://read.qxmd.com/read/37437774/anti-nc16a-iga-from-linear-iga-bullous-dermatosis-patients-induce-neutrophil-dependent-subepidermal-blistering-in-mice
#39
JOURNAL ARTICLE
Ke Jing, Tyler J M Jordan, Ning Li, Susan Burette, Baoqi Yang, M Peter Marinkovich, Luis A Diaz, Paul Googe, Nancy E Thomas, Suying Feng, Zhi Liu
Linear IgA bullous dermatosis (LABD) is an acquired autoimmune subepidermal blistering skin disease characterized by circulating and tissue-bound IgA autoantibodies that recognize epitopes within the hemidesmosomal protein BP180, including its NC16A domain. Histologically, LABD has long been defined by neutrophil infiltration and dermal-epidermal separation. However, the pathogenic roles of anti-NC16A IgA and neutrophils in LABD, as well as their interactions, have not been thoroughly studied. We show that passive transfer of patient-derived anti-NC16A IgA induce clinical and histologic LABD pathology in humanized NC16A mice that are reconstituted locally or systemically with human neutrophils...
July 10, 2023: Journal of Investigative Dermatology
https://read.qxmd.com/read/37426371/rituximab-for-linear-immunoglobulin-a-bullous-dermatosis
#40
JOURNAL ARTICLE
Rummit Dhillon, Lily Park, Sarah Gabros, Tam Nguyen, Stanley Skopit
Linear immunoglobulin A bullous dermatosis (LABD) is an idiopathic or drug-induced vesiculobullous disease typically managed with dapsone or colchicine. We report a case of LABD successfully treated with rituximab in a patient who was intolerant to first-line therapies and recalcitrant to typical immunosuppressants. The patient was initially started on prednisone and mycophenolate mofetil which resulted in minimal response and disease progression. Improvement was seen after two infusions of rituximab 1000 mg at 2 weeks apart with planned maintenance therapy...
June 7, 2023: Dermatology Reports
keyword
keyword
25431
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.